Kymera Therapeutic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KYMR and other ETFs, options, and stocks.About KYMR
Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi on September 29, 2015 and is headquartered in Watertown, MA.
CEONello Mainolfi
CEONello Mainolfi
Employees188
Employees188
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2015
Founded2015
Employees188
Employees188
KYMR Key Statistics
Market cap6.63B
Market cap6.63B
Price-Earnings ratio-23.35
Price-Earnings ratio-23.35
Dividend yield—
Dividend yield—
Average volume2.34M
Average volume2.34M
High today$85.00
High today$85.00
Low today$81.12
Low today$81.12
Open price$81.30
Open price$81.30
Volume1.45M
Volume1.45M
52 Week high$103.00
52 Week high$103.00
52 Week low$19.45
52 Week low$19.45
Stock Snapshot
With a market cap of 6.63B, Kymera Therapeutic(KYMR) trades at $84.72. The stock has a price-to-earnings ratio of -23.35.
On 2025-12-20, Kymera Therapeutic(KYMR) stock moved within a range of $81.12 to $85.00. With shares now at $84.72, the stock is trading +4.4% above its intraday low and -0.3% below the session's peak.
Trading volume for Kymera Therapeutic(KYMR) stock has reached 1.45M, versus its average volume of 2.34M.
Over the past 52 weeks, Kymera Therapeutic(KYMR) stock has traded between a high of $103.00 and a low of $19.45.
Over the past 52 weeks, Kymera Therapeutic(KYMR) stock has traded between a high of $103.00 and a low of $19.45.
Analyst ratings
96%
of 24 ratingsBuy
95.8%
Hold
0%
Sell
4.2%
People also own
Based on the portfolios of people who own KYMR. This list is generated using Robinhood data, and it’s not a recommendation.